139 related articles for article (PubMed ID: 31232189)
1. Identifying potential GluN2B subunit containing N-Methyl-D-aspartate receptor inhibitors: an integrative
Singh R; Ganeshpurkar A; Kumar D; Kumar D; Kumar A; Singh SK
J Biomol Struct Dyn; 2020 Jun; 38(9):2533-2545. PubMed ID: 31232189
[TBL] [Abstract][Full Text] [Related]
2. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.
Müller MK; Jacobi E; Sakimura K; Malinow R; von Engelhardt J
Acta Neuropathol Commun; 2018 Oct; 6(1):110. PubMed ID: 30352630
[TBL] [Abstract][Full Text] [Related]
3. An in-silico investigation based on molecular simulations of novel and potential brain-penetrant GluN2B NMDA receptor antagonists as anti-stroke therapeutic agents.
El Fadili M; Er-Rajy M; Ali Eltayb W; Kara M; Imtara H; Zarougui S; Al-Hoshani N; Hamadi A; Elhallaoui M
J Biomol Struct Dyn; 2024 Aug; 42(12):6174-6188. PubMed ID: 37428078
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of GluN2B pathway is involved in the neuroprotective effect of silibinin on streptozotocin-induced Alzheimer's disease models.
Liu P; Wang C; Chen W; Kang Y; Liu W; Qiu Z; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
Phytomedicine; 2023 Jan; 109():154594. PubMed ID: 36610115
[TBL] [Abstract][Full Text] [Related]
5. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.
Ferreira IL; Bajouco LM; Mota SI; Auberson YP; Oliveira CR; Rego AC
Cell Calcium; 2012 Feb; 51(2):95-106. PubMed ID: 22177709
[TBL] [Abstract][Full Text] [Related]
6. Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity.
Huang Y; Shen W; Su J; Cheng B; Li D; Liu G; Zhou WX; Zhang YX
J Alzheimers Dis; 2017; 57(3):885-897. PubMed ID: 28269783
[TBL] [Abstract][Full Text] [Related]
7. Computational investigation of phytochemicals from
Ahmad I; Kumar D; Patel H
J Biomol Struct Dyn; 2022 Oct; 40(17):7991-8003. PubMed ID: 33970806
[No Abstract] [Full Text] [Related]
8. Pharmacology of triheteromeric N-Methyl-D-Aspartate Receptors.
Cheriyan J; Balsara RD; Hansen KB; Castellino FJ
Neurosci Lett; 2016 Mar; 617():240-6. PubMed ID: 26917100
[TBL] [Abstract][Full Text] [Related]
9. A common mechanism allows selective targeting of GluN2B subunit-containing
Schreiber JA; Schepmann D; Frehland B; Thum S; Datunashvili M; Budde T; Hollmann M; Strutz-Seebohm N; Wünsch B; Seebohm G
Commun Biol; 2019; 2():420. PubMed ID: 31754650
[No Abstract] [Full Text] [Related]
10. Involvement of GluN2B subunit containing N-methyl-d-aspartate (NMDA) receptors in mediating the acute and chronic synaptotoxic effects of oligomeric amyloid-beta (Aβ) in murine models of Alzheimer's disease (AD).
Rammes G; Mattusch C; Wulff M; Seeser F; Kreuzer M; Zhu K; Deussing JM; Herms J; Parsons CG
Neuropharmacology; 2017 Sep; 123():100-115. PubMed ID: 28174113
[TBL] [Abstract][Full Text] [Related]
11. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
[TBL] [Abstract][Full Text] [Related]
12. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.
Stroebel D; Buhl DL; Knafels JD; Chanda PK; Green M; Sciabola S; Mony L; Paoletti P; Pandit J
Mol Pharmacol; 2016 May; 89(5):541-51. PubMed ID: 26912815
[TBL] [Abstract][Full Text] [Related]
13. Exploring the overlapping binding sites of ifenprodil and EVT-101 in GluN2B-containing NMDA receptors using novel chicken embryo forebrain cultures and molecular modeling.
Fjelldal MF; Freyd T; Evenseth LM; Sylte I; Ring A; Paulsen RE
Pharmacol Res Perspect; 2019 Jun; 7(3):e00480. PubMed ID: 31164987
[TBL] [Abstract][Full Text] [Related]
14. Exploration of the potential neuroprotective compounds targeting GluN1-GluN2B NMDA receptors.
He M; Wang Y; Zhang X; Zhang L
J Biomol Struct Dyn; 2023 Dec; 41(20):10900-10908. PubMed ID: 36591642
[TBL] [Abstract][Full Text] [Related]
15. Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease.
Hanson JE; Pare JF; Deng L; Smith Y; Zhou Q
Neurobiol Dis; 2015 Feb; 74():254-62. PubMed ID: 25484285
[TBL] [Abstract][Full Text] [Related]
16. Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release.
Ferreira IL; Ferreiro E; Schmidt J; Cardoso JM; Pereira CM; Carvalho AL; Oliveira CR; Rego AC
Neurobiol Aging; 2015 Feb; 36(2):680-92. PubMed ID: 25442114
[TBL] [Abstract][Full Text] [Related]
17. Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells.
Li Y; Chang L; Song Y; Gao X; Roselli F; Liu J; Zhou W; Fang Y; Ling W; Li H; Almeida OF; Wu Y
J Alzheimers Dis; 2016 Aug; 54(1):135-48. PubMed ID: 27497478
[TBL] [Abstract][Full Text] [Related]
18. Dysfunctional synapse in Alzheimer's disease - A focus on NMDA receptors.
Mota SI; Ferreira IL; Rego AC
Neuropharmacology; 2014 Jan; 76 Pt A():16-26. PubMed ID: 23973316
[TBL] [Abstract][Full Text] [Related]
19. Targeting NMDA receptor in Alzheimer's disease: identifying novel inhibitors using computational approaches.
Siddiqui AJ; Badraoui R; Jahan S; Alshahrani MM; Siddiqui MA; Khan A; Adnan M
Front Pharmacol; 2023; 14():1208968. PubMed ID: 37416066
[TBL] [Abstract][Full Text] [Related]
20. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers.
Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST
J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
